Most of the patients experienced just one AE requiring medical management. The most frequent category 4SC-202 mw of AE medical management agent was antiemetics and antinauseants,
the most expensive category of medication was immunostimulants, ranging from € 785 to € 3,051 per episode (Table 7). Table 7 Cost of adverse event management for most commonly APR-246 concentration prescribed agents (occurring in ≥ 5% of patients Category of adverse event management Most frequent medical agent(s) Percentage of events treated with agent Unit cost per day (€ 2009) Mean duration (days) Cost per event (€ 2009) Antiemetics and antinauseants Ondansetron (1), (2) 90,7 5,99 66,5 56,9 Drugs for acid related disorders Omeprazole 75 0,25 99,5 24,9 Corticosteroids for systemic use Dexamethasone 50 0,8 133,3 106,6 Analgesics Co-efferalgan 30,8 0,52 48,5 25,2 Tramadol 30,8 1,92 25,5 49 Drugs for functional gastrointestinal disorders Metoclopramide 100 0,92 97,5 89,7 Immunostimulants Filgrastim (3) 44,4
65,42 23,2 785 Lenograstim 11,1 79,39 12 952,7 Pegfilgrastim (4) 11,1 902,48 71 3051,2 (1) Assumed maximum duration 3 days per 21-day cycle throughout observed mean duration. (2) Unit cost is per day, given once per 21-day cycle throughout observed mean duration. (3) Assumed maximum duration 12 days; if observed mean duration of 23,2 days is used, then total cost is 1517,7. (4) CP673451 order Unit cost is per cycle, given once per 21-day cycle throughout observed mean duration. Radiotherapy Among patients who received systemic therapy, 19.7% received radiotherapy in combination (Tables 8 and 9). Radiotherapy costs were based on standard protocols regimens. Mean cost per patient
receiving radiotherapy was equal to the unit cost of this resource (€ 2.814). Mean cost per patient for the generality of the sample resulted equal to € 555. Small differences in mean cost per patient with any response (€ 506) vs no response (€591) Parvulin are due to the different frequency in the resource use (18.05% vs 21%). Table 8 Summary statistics for radiotherapy for patients receiving systemic therapy Overall First-line therapy Second-line therapy Third-line therapy N 208 147 112 41 Patients with any radiotherapy N 41 24 13 6 % 19,7% 16,3% 11,6% 14,6% Incidence of radiotherapy (per patient with any radiotherapy per month (1)) Mean 0,1 0,31 0,27 0,14 95% CI 0,08-0,13 0,13-0,5 0,07-0,46 0,03-0,24 Total radiotherapy cost per patient with any radiotherapy (€ 2009) Mean 2.814 2.814 2.814 2.814 Total radiotherapy cost per patient with any radiotherapy per month (€ 2009) Mean 300 900 800 400 95% CI 200-400 400-1.400 200-1.300 100-700 Total radiotherapy cost per patient (€ 2009) Mean 555 459 327 412 (1) month of follow-up.